2,684 reports of this reaction
2.7% of all BOSENTAN reports
#3 most reported adverse reaction
PNEUMONIA is the #3 most commonly reported adverse reaction for BOSENTAN, manufactured by Actelion Pharmaceuticals US, Inc.. There are 2,684 FDA adverse event reports linking BOSENTAN to PNEUMONIA. This represents approximately 2.7% of all 98,401 adverse event reports for this drug.
Patients taking BOSENTAN who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for BOSENTAN, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for BOSENTAN:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 2,684 FDA reports for BOSENTAN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.7% of all adverse event reports for BOSENTAN, making it one of the most commonly reported side effect.
If you experience pneumonia while taking BOSENTAN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.